| | Title | Authors / Editors | Date |
|
unige:7134 |
Glitazones in lipodystrophy syndrome induced by highly active antiretroviral therapy |
Calmy, Alexandra; Hirschel, Bernard; Hans, Didier; Karsegard, V. L.; Meier, C. A. |
2003 |
|
unige:7130 |
HIV viral load monitoring in resource-limited regions: optional or necessary? |
Calmy, Alexandra; Ford, Nathan; Hirschel, Bernard; Reynolds, S. J.; ... Rodriguez, William |
2007 |
|
unige:7133 |
Clinical update: adverse effects of antiretroviral therapy |
Calmy, Alexandra; Hirschel, Bernard; Cooper, David; Carr, Andrew |
2007 |
|
unige:9296 |
Dix ans de lipodystrophie (1998-2008) : un syndrome encore méconnu |
Calmy, Alexandra; Bernasconi, Enos; Meier, Christoph A; Hirschel, Bernard; Toutous Trellu, Laurence Marie |
2008 |
|
unige:2093 |
Initial treatment for HIV infection--an embarrassment of riches |
Hirschel, Bernard; Calmy, Alexandra |
2008 |
|
unige:763 |
Lipodystrophy and weight changes: data from the Swiss HIV Cohort Study, 2000-2006 |
Nguyen, Alexandra; Calmy, Alexandra; Schiffer, V.; Bernasconi, Enos; ... Hirschel, Bernard |
2008 |
|
unige:147762 |
10 Jahren Lipodystrophie (1998-2008): Die "Groupe Lipo" der Hôpitaux universitaires de Genève: Ein Beratungsangebot für VIH-Positive mit dem Lipodystrophie-Syndrome |
Toutous Trellu, Laurence Marie; Calmy, Alexandra |
2008 |
|
unige:9288 |
Education thérapeutique en maladie infectieuse : l'exemple de l'infection à VIH |
Barthassat, V.; Calmy, Alexandra; Amati, F.; Vincent-Suter, S.; ... Golay, Alain |
2009 |
|
unige:9297 |
A new era of antiretroviral drug toxicity |
Calmy, Alexandra; Hirschel, Bernard; Cooper, D. A.; Carr, Andrew |
2009 |
|
unige:9298 |
Safety and efficacy of once-daily nevirapine dosing: a multicohort study |
Calmy, Alexandra; Vallier, Nathalie; Nguyen, Alain; Lange, J. M.; ... Wit, F. W. |
2009 |
|
unige:7131 |
Low bone mineral density, renal dysfunction, and fracture risk in HIV infection: a cross-sectional study |
Calmy, Alexandra; Fux, C. A.; Norris, Richard; Vallier, Nathalie; ... Carr, Andrew |
2009 |
|
unige:7132 |
HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial |
Calmy, Alexandra; Gayet-Ageron, Angèle; Montecucco, Fabrizio; Nguyen, Alain; ... Ananworanich, Jintanat |
2009 |
|
unige:20513 |
Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study |
Marzolini, Catia; Elzi, Luigia; Gibbons, Sara; Weber, Rainer; ... Battegay, Manuel |
2010 |
|
unige:5998 |
Optimizing HIV drug therapy |
Calmy, Alexandra |
2010 |
|
unige:7209 |
Infrequent replication of parvovirus B19 and erythrovirus genotypes 2 and 3 among HIV-infected patients with chronic anemia |
Ferry, Tristan; Hirschel, Bernard; Dang, Thanh; Meylan, Pascal; ... Calmy, Alexandra |
2010 |
|
unige:21174 |
Pharmacokinetics and pharmacogenomics of once-daily raltegravir and atazanavir in healthy volunteers |
Neely, Michael; Decosterd, Laurent; Fayet, Aurelie; Lee, Janice Soo Fern; ... Calmy, Alexandra |
2010 |
|
unige:21237 |
Treatment failure and mortality factors in patients receiving second-line HIV therapy in resource-limited countries |
Pujades-Rodriguez, Mar; Balkan, Suna; Arnould, Line; Brinkhof, Martin A. W.; Calmy, Alexandra |
2010 |
|
unige:21312 |
Cognitive dysfunction in HIV patients despite long-standing suppression of viremia |
Simioni, Samanta; Cavassini, Matthias; Annoni, Gian-Maria; Rimbault Abraham, Aline; ... Du Pasquier, Renaud A. |
2010 |
|
unige:21357 |
Patient needs and point-of-care requirements for HIV load testing in resource-limited settings |
Usdin, Martine; Guillerm, Martine; Calmy, Alexandra |
2010 |
|
unige:21098 |
ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir |
Lubomirov, Rubin; di Iulio, J.; Fayet, A.; Colombo, Sara; ... Telenti, A. |
2010 |
Calmy, Alexandra
add all
remove all
